Charles River Laboratories Intl. (NYSE:CRL) reported Q4 2017 earnings this Morning, coming in at $1.40 per share, beating Wall Street’s estimates of $1.26 per Share. Revenue for the quarter came in at $478.50 million beating analyst estimates of $475.02 million Recent Insider Trading for Charles River Laboratories Intl. (NYSE:CRL)
- On 1/18/2018 Online Communications Bdirect, Director, sold 131,000 with an average share price of $0.29 per share and the total transaction amounting to $37,990.00.
- On 1/2/2018 David Ross Smith, Insider, sold 5,486 with an average share price of $109.53 per share and the total transaction amounting to $600,881.58.
- On 1/2/2018 James C Foster, Chairman, sold 4,967 with an average share price of $109.44 per share and the total transaction amounting to $543,588.48.
- On 1/2/2018 Robert J Bertolini, Director, sold 3,609 with an average share price of $110.22 per share and the total transaction amounting to $397,783.98.
- On 12/12/2017 Kevin Ma, Director, sold 40,384 with an average share price of $0.41 per share and the total transaction amounting to $16,557.44.
- On 12/6/2017 C Richard Reese, Director, sold 10,227 with an average share price of $102.40 per share and the total transaction amounting to $1,047,244.80.
Recent Trading for Charles River Laboratories Intl. (NYSE:CRL) Shares of Charles River Laboratories Intl. closed the previous trading session at 101.99 down -0.02 0.02% with 100.23999786376953 shares trading hands.